Single whole-genome sequencing analysis of metastatic biopsy is sufficient for investigational treatment opportunities in cancer.
作者信息
Dong Xifeng, Fu Rong
机构信息
Department of Hematology, Tianjin Medical University General Hospital, Tianjin, P. R. China.
出版信息
Cancer Commun (Lond). 2021 Dec;41(12):1417-1419. doi: 10.1002/cac2.12232. Epub 2021 Oct 17.
Abstract
摘要
相似文献
1
Single whole-genome sequencing analysis of metastatic biopsy is sufficient for investigational treatment opportunities in cancer.转移性活检的单全基因组测序分析足以提供癌症研究性治疗机会。
Cancer Commun (Lond). 2021 Dec;41(12):1417-1419. doi: 10.1002/cac2.12232. Epub 2021 Oct 17.
2
Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH).基于基因组的癌症临床试验的分子图谱和可操作的改变：美国国立癌症研究所分子分析用于治疗选择（NCI-MATCH）。
J Clin Oncol. 2020 Nov 20;38(33):3883-3894. doi: 10.1200/JCO.19.03010. Epub 2020 Oct 13.
3
DNA repair: a reinvigorated therapeutic target.DNA修复：一个重新焕发生机的治疗靶点。
Clin Cancer Res. 2010 Sep 15;16(18):4510. doi: 10.1158/1078-0432.CCR-10-2086. Epub 2010 Sep 7.
4
[New therapeutic strategies in oncology].[肿瘤学中的新治疗策略]
Ann Pharm Fr. 2010 Jul;68(4):203-4. doi: 10.1016/j.pharma.2010.06.001.
5
Real-world utilization of molecular diagnostic testing and matched drug therapies in the treatment of metastatic cancers.分子诊断检测与匹配药物疗法在转移性癌症治疗中的真实世界应用。
J Med Econ. 2018 Jun;21(6):543-552. doi: 10.1080/13696998.2017.1423488. Epub 2018 Jan 19.
6
Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care.同步护理：一种应对试验性治疗与姑息治疗之间感知冲突的模式方法。
J Pain Symptom Manage. 2004 Dec;28(6):548-56. doi: 10.1016/j.jpainsymman.2004.03.002.
7
The war on cancer.
Hastings Cent Rep. 2003 Jul-Aug;33(4):5.
8
The evidence framework for precision cancer medicine.精准肿瘤医学的证据基础。
Nat Rev Clin Oncol. 2018 Mar;15(3):183-192. doi: 10.1038/nrclinonc.2017.186. Epub 2017 Dec 19.
9
Use of off-label drugs in cancer care again under review.
ONS News. 2005 Mar;20(3):8.
10
Firms combine experimental cancer drugs to speed development.
Nat Biotechnol. 2010 Aug;28(8):765-6. doi: 10.1038/nbt0810-765.
引用本文的文献
1
Genomic and Clinical Analysis of Children with Acute Lymphoblastic Leukemia.儿童急性淋巴细胞白血病的基因组和临床分析。
Comput Math Methods Med. 2022 Aug 16;2022:7904293. doi: 10.1155/2022/7904293. eCollection 2022.
本文引用的文献
1
Limited evolution of the actionable metastatic cancer genome under therapeutic pressure.在治疗压力下，可操作转移性癌症基因组的有限进化。
Nat Med. 2021 Sep;27(9):1553-1563. doi: 10.1038/s41591-021-01448-w. Epub 2021 Aug 9.
2
Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics.临床验证全基因组测序在癌症诊断中的应用。
J Mol Diagn. 2021 Jul;23(7):816-833. doi: 10.1016/j.jmoldx.2021.04.011. Epub 2021 May 6.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Cancer burden of major cancers in China: A need for sustainable actions.中国主要癌症的癌症负担：需要采取可持续行动。
Cancer Commun (Lond). 2020 May;40(5):205-210. doi: 10.1002/cac2.12025. Epub 2020 May 2.
5
Clinicopathological features of pseudomyogenic hemangioendothelioma and precision therapy based on whole exome sequencing.假性肌源性血管内皮瘤的临床病理特征及基于全外显子组测序的精准治疗
Cancer Commun (Lond). 2020 Apr;40(4):197-201. doi: 10.1002/cac2.12020. Epub 2020 Mar 30.
6
The mutational footprints of cancer therapies.癌症治疗的突变足迹。
Nat Genet. 2019 Dec;51(12):1732-1740. doi: 10.1038/s41588-019-0525-5. Epub 2019 Nov 18.
7
Pan-cancer whole-genome analyses of metastatic solid tumours.泛癌种实体瘤全基因组分析。
Nature. 2019 Nov;575(7781):210-216. doi: 10.1038/s41586-019-1689-y. Epub 2019 Oct 23.
8
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs.药物再发现方案促进了现有抗癌药物的广泛应用。
Nature. 2019 Oct;574(7776):127-131. doi: 10.1038/s41586-019-1600-x. Epub 2019 Sep 30.
9
Biomarker-guided therapy for colorectal cancer: strength in complexity.生物标志物指导的结直肠癌治疗：复杂性中的优势。
Nat Rev Clin Oncol. 2020 Jan;17(1):11-32. doi: 10.1038/s41571-019-0241-1. Epub 2019 Jul 9.
10
Somatic mutations in renal cell carcinomas from Chinese patients revealed by targeted gene panel sequencing and their associations with prognosis and PD-L1 expression.通过靶向基因panel测序揭示的中国患者肾细胞癌中的体细胞突变及其与预后和PD-L1表达的关联。
Cancer Commun (Lond). 2019 Jun 21;39(1):37. doi: 10.1186/s40880-019-0382-8.
Zotero 插件